EU SolidAct: An Adaptive Pandemic and Emerging Infection Platform Trial

Clinical trial NCT04891133 · TERMINATED

Trial details

NCT number: NCT04891133
Sponsor: Oslo University Hospital
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

COVID-19 Emerging Infectious Disease

Start date: 2021-06-03
Primary completion: 2022-12-15
Enrollment: 290

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.